Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Prediction of benefit from adjuvant treatment in patients with breast cancer.

Eng-Wong J, Isaacs C.

Clin Breast Cancer. 2010;10 Suppl 1:E32-7. doi: 10.3816/CBC.2010.s.005.

PMID:
20587405
[PubMed - indexed for MEDLINE]
2.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
3.

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.

Albain KS, Paik S, van't Veer L.

Breast. 2009 Oct;18 Suppl 3:S141-5. doi: 10.1016/S0960-9776(09)70290-5. Review.

PMID:
19914534
[PubMed - indexed for MEDLINE]
4.

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.

Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.

PMID:
18159035
[PubMed - indexed for MEDLINE]
5.

Impact of gene expression profiling tests on breast cancer outcomes.

Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN.

Evid Rep Technol Assess (Full Rep). 2007 Dec;(160):1-105. Review.

PMID:
18457476
[PubMed - indexed for MEDLINE]
Free Article
6.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
7.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
[PubMed - indexed for MEDLINE]
8.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

PMID:
17610808
[PubMed - indexed for MEDLINE]
Free Article
9.

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.

Kao KJ, Chang KM, Hsu HC, Huang AT.

BMC Cancer. 2011 Apr 18;11:143. doi: 10.1186/1471-2407-11-143.

PMID:
21501481
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Use of the Oncotype DX 21-gene assay to guide adjuvant decision making in early-stage breast cancer.

Conlin AK, Seidman AD.

Mol Diagn Ther. 2007;11(6):355-60. Review.

PMID:
18078353
[PubMed - indexed for MEDLINE]
11.

Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?

Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, Osborne MP, Boachie-Adjei K, Twardzik W, Tartter PI.

Am J Surg. 2008 Oct;196(4):527-9. doi: 10.1016/j.amjsurg.2008.06.021.

PMID:
18809056
[PubMed - indexed for MEDLINE]
12.

Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer.

Henry NL, Hayes DF.

Oncology (Williston Park). 2007 Oct;21(11):1301-9; discussion 1311, 1314, 1319. Review.

PMID:
18080616
[PubMed - indexed for MEDLINE]
14.

Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?

Naeim A, Keeler EB.

Breast Cancer Res Treat. 2005 Nov;94(2):95-103.

PMID:
16261407
[PubMed - indexed for MEDLINE]
15.

Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy.

Andre F, Pusztai L.

Nat Clin Pract Oncol. 2006 Nov;3(11):621-32. Review.

PMID:
17080180
[PubMed - indexed for MEDLINE]
16.

Reducing the risk of late recurrence in hormone-responsive breast cancer.

Cufer T.

Ann Oncol. 2007 Sep;18 Suppl 8:viii18-25. Review.

PMID:
17890210
[PubMed - indexed for MEDLINE]
Free Article
17.

Genomic predictors of outcome and treatment response in breast cancer.

Dunn L, Demichele A.

Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.

PMID:
19537843
[PubMed - indexed for MEDLINE]
18.

Systematic review: gene expression profiling assays in early-stage breast cancer.

Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN.

Ann Intern Med. 2008 Mar 4;148(5):358-69. Epub 2008 Feb 4. Review.

PMID:
18252678
[PubMed - indexed for MEDLINE]
19.

Early breast cancer in the elderly: assessment and management considerations.

Albrand G, Terret C.

Drugs Aging. 2008;25(1):35-45. Review.

PMID:
18184027
[PubMed - indexed for MEDLINE]
20.

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

Jahanzeb M.

Clin Ther. 2007 Aug;29(8):1535-47. Review.

PMID:
17919537
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk